Frequently Asked Questions
The market is segmented based on , By Function (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Library and Database Preparation, and Others), Solutions (Software, and Services), Technique (Drug Discovery, and Drug Development), Mode (In-House Informatics, and Outsourced Informatics), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), and Others) – Industry Trends and Forecast to 2031.
.
The Global Drug Discovery Informatics Market size was valued at USD 3.11 USD Billion in 2023.
The Global Drug Discovery Informatics Market is projected to grow at a CAGR of 11.77% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
